CuraTeQ Biologics gets Health Canada approval for Bevqolva cancer treatment
NewsBytes | May 1, 2026 7:40 PM CST
CuraTeQ has 2 biosimilars under review
Bevqolva works by blocking new blood vessels that help tumors grow, making it a key option for cancer treatment.
This approval is a big step for CuraTeQ as it expands its lineup of biosimilars. It also has two more similar drugs under review in Canada.
READ NEXT
-
Oppo Reno 16 Series Tipped for Launch Soon: 7000mAh Battery, 200MP Camera May Steal the Spotlight
-
IPL 2026: Five Umpiring Decisions That Triggered Major Controversy
-
TMC Gears Up For Counting: Mamata, Abhishek Call Key Meeting On May 2
-
Man detained after digging pit amid human sacrifice rumour in Chamarajanagara
-
May bank holiday alert issued to millions across UK, BBC expert shares
